These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 26026287

  • 1. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
    Brayden DJ, Maher S, Bahar B, Walsh E.
    Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
    [Abstract] [Full Text] [Related]

  • 2. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
    Brayden DJ, Walsh E.
    AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
    [Abstract] [Full Text] [Related]

  • 3. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C10).
    Twarog C, Liu K, O'Brien PJ, Dawson KA, Fattal E, Illel B, Brayden DJ.
    Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C10): Isolated rat intestinal mucosae and sacs.
    Twarog C, McCartney F, Harrison SM, Illel B, Fattal E, Brayden DJ.
    Eur J Pharm Sci; 2021 Mar 01; 158():105685. PubMed ID: 33359131
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
    Maher S, Kennelly R, Bzik VA, Baird AW, Wang X, Winter D, Brayden DJ.
    Eur J Pharm Sci; 2009 Nov 05; 38(4):291-300. PubMed ID: 19737613
    [Abstract] [Full Text] [Related]

  • 6. Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.
    Stuettgen V, Brayden DJ.
    AAPS J; 2020 Jan 27; 22(2):33. PubMed ID: 31989362
    [Abstract] [Full Text] [Related]

  • 7. Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate.
    Wang X, Maher S, Brayden DJ.
    Ther Deliv; 2010 Jul 27; 1(1):75-82. PubMed ID: 22816121
    [Abstract] [Full Text] [Related]

  • 8. LabrafacTM MC60 is an efficacious intestinal permeation enhancer for macromolecules: Comparisons with Labrasol® ALF in ex vivo and in vivo rat studies.
    McCartney F, Caisse P, Dumont C, Brayden DJ.
    Int J Pharm; 2024 Aug 15; 661():124353. PubMed ID: 38909926
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Labrasol® and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae.
    Heade J, Maher S, Bleiel SB, Brayden DJ.
    J Pharm Sci; 2018 Jun 15; 107(6):1648-1655. PubMed ID: 29462634
    [Abstract] [Full Text] [Related]

  • 11. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
    Maher S, Medani M, Carballeira NN, Winter DC, Baird AW, Brayden DJ.
    AAPS J; 2017 Jan 15; 19(1):244-253. PubMed ID: 27739012
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers.
    Maher S, Feighery L, Brayden DJ, McClean S.
    Pharm Res; 2007 Jul 15; 24(7):1336-45. PubMed ID: 17373574
    [Abstract] [Full Text] [Related]

  • 15. Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae.
    Maher S, Feighery L, Brayden DJ, McClean S.
    Pharm Res; 2007 Jul 15; 24(7):1346-56. PubMed ID: 17380268
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.
    Feighery LM, Cochrane SW, Quinn T, Baird AW, O'Toole D, Owens SE, O'Donoghue D, Mrsny RJ, Brayden DJ.
    Pharm Res; 2008 Jun 15; 25(6):1377-86. PubMed ID: 18163202
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
    Sakai M, Imai T, Ohtake H, Azuma H, Otagiri M.
    J Pharm Sci; 1997 Jul 15; 86(7):779-85. PubMed ID: 9232516
    [Abstract] [Full Text] [Related]

  • 20. Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells.
    Tomita M, Hayashi M, Awazu S.
    J Pharmacol Exp Ther; 1995 Feb 15; 272(2):739-43. PubMed ID: 7853188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.